Harper S J F, Goncalves I, Doughman T, Nicholson M L
Transplantation Division, Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK.
Transplantation Division, Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK.
Eur J Vasc Endovasc Surg. 2008 Aug;36(2):237-241. doi: 10.1016/j.ejvs.2008.02.012. Epub 2008 Apr 18.
The expanding haemodialysis population has lead to increased requirement for more complex vascular access. The aim of this study is to present the results of an extensive series of brachiobasilic arteriovenous fistulae.
BBAVF were performed using single-stage vein transposition. A retrospective review of case notes was performed.
One hundred and sixty eight BBAVF were created in 144 patients. This was the first access procedure in only 30 cases and the fourth or fifth in 30. At 24h, 165 fistulas (98%) were patent. One hundred and eleven fistulas (66%) were used for haemodialysis and 57 (34%) were never used, of which 39 (23%) were due to fistula failure. The cumulative secondary patency at 1, 2 and 3 years was 66%, 50% and 41% respectively. There were 201 complications in 119 patients (71%), including thrombosis (29%), arm oedema (17%), infection (13%) and arterial steal syndrome (11%). Ten angioplasties and 48 operative procedures were performed for complications. Pre-operative ipsilateral subclavian catheter had been placed in 62 cases (37%) and was associated with poor patency.
BBAVF represents an important option for vascular access with acceptable patency rates, although complication rates remain significant.
血液透析人群不断扩大,导致对更复杂血管通路的需求增加。本研究的目的是展示一系列广泛的肱动脉 - 贵要静脉动静脉内瘘的结果。
采用单阶段静脉转位术构建肱动脉 - 贵要静脉内瘘。对病例记录进行回顾性分析。
144例患者共构建了168个肱动脉 - 贵要静脉内瘘。仅30例是首次进行血管通路手术,30例是第四次或第五次进行。术后24小时,165个内瘘(98%)通畅。111个内瘘(66%)用于血液透析,57个(34%)从未使用,其中39个(23%)是由于内瘘失败。1年、2年和3年的累积二次通畅率分别为66%、50%和41%。119例患者(71%)出现201例并发症,包括血栓形成(29%)、手臂水肿(17%)、感染(13%)和动脉窃血综合征(11%)。针对并发症进行了10次血管成形术和48次手术。62例(37%)术前同侧锁骨下静脉置管,其通畅性较差。
肱动脉 - 贵要静脉内瘘是一种重要的血管通路选择,通畅率尚可,但并发症发生率仍然较高。